Poniard Pharmaceuticals Inc (PARD) Stock Price, Quote, News & History

PARDOTCEM
$0.000010
-0.00009-90.00%
At close: Dec 15, 4:00 PM EST
OverviewNews
Loading...

Key Statistics

Open
-
Close
$0.00
Volume / Avg.
0 / 100.00
Day Range
- - -
52 Wk Range
0.00 - 0.00
Market Cap
$14.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
-

Recent Poniard Pharmaceuticals Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.46M
Investing Cash Flow (TTM)
12.23M
Financing Cash Flow (TTM)
-10.81M
Free Cash Flow (TTM)
-10.47M
Capital Expenditure (TTM)
-9.00K
Net Change in Cash (TTM)
-9.03M

Valuation Metrics

Enterprise Value
$299.85K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$13.80M
Total Cash
$1.98M
Debt to Equity
0.53
Issuance of Debt (TTM)
-$13.80M
Repayment of Debt (TTM)
-$13.80M

Key Statistics

Open
-
Close
$0.00
Volume / Avg.
0 / 100.00
Day Range
- - -
52 Wk Range
0.00 - 0.00
Market Cap
$14.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
-

About

Sector
Health Care
Industry
Biotechnology
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Poniard Pharmaceuticals (PARD) stock?

A

You can purchase shares of Poniard Pharmaceuticals (OTCEM:PARD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Poniard Pharmaceuticals (PARD) competitors?

A

There are no as such competitors for Poniard Pharmaceuticals.

Q

What is the forecast, or price target, for Poniard Pharmaceuticals (PARD) stock?

A

There is no analysis for Poniard Pharmaceuticals to provide a consensus price target.

Q

What is the current price for Poniard Pharmaceuticals (PARD)?

A

The stock price for Poniard Pharmaceuticals (OTCEM: PARD) is $0.00001 last updated April 2, 2026 at 3:49 PM EDT.

Q

Does Poniard Pharmaceuticals (PARD) pay a dividend?

A

There are no upcoming dividends for Poniard Pharmaceuticals.

Q

When is Poniard Pharmaceuticals (OTCEM:PARD) reporting earnings?

A

Poniard Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Poniard Pharmaceuticals (PARD) going to split?

A

There is no upcoming split for Poniard Pharmaceuticals.

Q

What sector and industry does Poniard Pharmaceuticals (PARD) operate in?

A

Poniard Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.